Alniditan

Alniditan
Clinical data
ATC code	none;
Identifiers
	IUPAC name N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine;
CAS Number	152317-89-0 ; Dihydrochloride: 155428-00-5 ;
PubChem CID	66004;
IUPHAR/BPS	120;
ChemSpider	59396 ;
UNII	B57Z82EOGE; Dihydrochloride: 54PE58MGKB ;
KEGG	D02826 ;
ChEMBL	ChEMBL88240 ;
Chemical and physical data
Formula	C17H26N4O
Molar mass	302.422 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CNC(=NC1)NCCCNCC2CCC3=CC=CC=C3O2;
	InChI InChI=1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)/t15-/m1/s1 ; Key:QVSXOXCYXPQXMF-OAHLLOKOSA-N ;
	(what is this?) (verify)

Alniditan is a 5-HT_1D receptor agonist with migraine-preventive effects.^[1]

^ Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, et al. (December 1996). "Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan". Molecular Pharmacology. 50 (6): 1567–1580. PMID 8967979.

Clinical data

ATC code	none
Identifiers
IUPAC name N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine
CAS Number	152317-89-0^Y Dihydrochloride: 155428-00-5^Y
PubChem CID	66004
IUPHAR/BPS	120
ChemSpider	59396^Y
UNII	B57Z82EOGE Dihydrochloride: 54PE58MGKB^Y
KEGG	D02826^Y
ChEMBL	ChEMBL88240^Y
Chemical and physical data
Formula	C₁₇H₂₆N₄O
Molar mass	302.422 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C1CNC(=NC1)NCCCNCC2CCC3=CC=CC=C3O2
InChI InChI=1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)/t15-/m1/s1^Y Key:QVSXOXCYXPQXMF-OAHLLOKOSA-N^Y
^NY (what is this?) (verify)